chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atelectasis, Blood alkaline phosphatase increased, Brain natriuretic peptide increased, COVID-19, Cardiac failure acute
Clinical narrative: Patient hospitalized with COVID-19;  Still hospitalized (ICU);  Fully vaccinated.   Admission Note H&P:  HISTORY OF PRESENT ILLNESS: Patient is a 73-year-old female with past medical history of diastolic CHF, hypertension, hyperlipidemia, seizure disorder s/p VNS, coronary artery disease status post CABG, sick sinus syndrome status post permanent pacemaker, CKD 3, diabetes type 2, GERD. Patient was recently hospitalized from 06/11/2021 to 6/20 3/21 for acute congestive heart failure found to have chronic diastolic CHF.  Patient during this visit was suicidal and was EN route to facility when she developed chest pain and taken to Hospital.  During hospitalization patient was noted to have chronic abdominal pain, a possible seizure that was followed up with an EEG and neuro evaluation all unremarkable.  Patient denies suicidal ideations once admitted therefore no further psych placement needed and she was discharged to subacute rehab. Today patient is coming from facility with complaints of altered mental status from baseline, increased fatigue, fevers, and hypoxia.  On 08/23 patient was diagnosed with COVID-19. Patient complains of some shortness of breath, cough, severe headache, abdominal pain but this appears chronic, numbness testing into her left lower leg.  States having reduced appetite but no loss of taste or smell. ASSESSMENT/PLAN: Severe COVID-19 infection with acute hypoxic respiratory failure - First onset of symptoms: unknown, roughly week - Tested Positive: 8/23 - Decadron: 6mg PO daily, day #1 - continue home PPI - Give Remdesivir      *Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required. - Oxygen Requirements: 2L, wean as tolerated - COVID lab panel:              - D-Dimer = ordered              - CRP = ordered              - alkaline phosphatase = 244 - DVT Prophylaxis: Heparin - treat CHF keeping euvolemic, encourage proning, IS - PRN albuterol, tessalon, tylenol   Superimposed Bacterial CAP - procal mildly elevated at 0.29 - ER started Rocephin day 1/5 and Azithromycin day 1/3 - sputum culture, legionella, strep pneumoniae, blood cultures ordered    Acute exacerbation of chronic diastolic CHF  -last echo 6/12/21 EF 57%, diastolic dysfunction grade 2, right ventricle mildly to moderately decreased, mild MR, moderate TR right ventricular systolic pressure 43.1 mmHg -chest x-ray shows findings of mild congestion; BNP 17,476 -start Lasix 40 mg IV push 2 times a day    *The patient is on IV Lasix which requires daily monitoring of electrolyte and renal function to monitor for the following toxicities:  renal failure, hyper/hyponatremia, hypokalemia, metabolic alkalosis. -2 L fluid restriction, strict I&Os, daily weights   Indeterminate high sensitivity troponins -trope 61 with a 2 hour delta of +3 -demand ischemia from CHF exacerbation and in the presence of CKD
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac failure congestive, Cardiomegaly, Chest X-ray abnormal, Chest pain, Computerised tomogram abdomen
Clinical narrative: Patient hospitalized with COVID-19;  Still hospitalized (ICU);  Fully vaccinated.   Admission Note H&P:  HISTORY OF PRESENT ILLNESS: Patient is a 73-year-old female with past medical history of diastolic CHF, hypertension, hyperlipidemia, seizure disorder s/p VNS, coronary artery disease status post CABG, sick sinus syndrome status post permanent pacemaker, CKD 3, diabetes type 2, GERD. Patient was recently hospitalized from 06/11/2021 to 6/20 3/21 for acute congestive heart failure found to have chronic diastolic CHF.  Patient during this visit was suicidal and was EN route to facility when she developed chest pain and taken to Hospital.  During hospitalization patient was noted to have chronic abdominal pain, a possible seizure that was followed up with an EEG and neuro evaluation all unremarkable.  Patient denies suicidal ideations once admitted therefore no further psych placement needed and she was discharged to subacute rehab. Today patient is coming from facility with complaints of altered mental status from baseline, increased fatigue, fevers, and hypoxia.  On 08/23 patient was diagnosed with COVID-19. Patient complains of some shortness of breath, cough, severe headache, abdominal pain but this appears chronic, numbness testing into her left lower leg.  States having reduced appetite but no loss of taste or smell. ASSESSMENT/PLAN: Severe COVID-19 infection with acute hypoxic respiratory failure - First onset of symptoms: unknown, roughly week - Tested Positive: 8/23 - Decadron: 6mg PO daily, day #1 - continue home PPI - Give Remdesivir      *Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required. - Oxygen Requirements: 2L, wean as tolerated - COVID lab panel:              - D-Dimer = ordered              - CRP = ordered              - alkaline phosphatase = 244 - DVT Prophylaxis: Heparin - treat CHF keeping euvolemic, encourage proning, IS - PRN albuterol, tessalon, tylenol   Superimposed Bacterial CAP - procal mildly elevated at 0.29 - ER started Rocephin day 1/5 and Azithromycin day 1/3 - sputum culture, legionella, strep pneumoniae, blood cultures ordered    Acute exacerbation of chronic diastolic CHF  -last echo 6/12/21 EF 57%, diastolic dysfunction grade 2, right ventricle mildly to moderately decreased, mild MR, moderate TR right ventricular systolic pressure 43.1 mmHg -chest x-ray shows findings of mild congestion; BNP 17,476 -start Lasix 40 mg IV push 2 times a day    *The patient is on IV Lasix which requires daily monitoring of electrolyte and renal function to monitor for the following toxicities:  renal failure, hyper/hyponatremia, hypokalemia, metabolic alkalosis. -2 L fluid restriction, strict I&Os, daily weights   Indeterminate high sensitivity troponins -trope 61 with a 2 hour delta of +3 -demand ischemia from CHF exacerbation and in the presence of CKD
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Computerised tomogram head abnormal, Condition aggravated, Cough, Decreased appetite
Clinical narrative: Patient hospitalized with COVID-19;  Still hospitalized (ICU);  Fully vaccinated.   Admission Note H&P:  HISTORY OF PRESENT ILLNESS: Patient is a 73-year-old female with past medical history of diastolic CHF, hypertension, hyperlipidemia, seizure disorder s/p VNS, coronary artery disease status post CABG, sick sinus syndrome status post permanent pacemaker, CKD 3, diabetes type 2, GERD. Patient was recently hospitalized from 06/11/2021 to 6/20 3/21 for acute congestive heart failure found to have chronic diastolic CHF.  Patient during this visit was suicidal and was EN route to facility when she developed chest pain and taken to Hospital.  During hospitalization patient was noted to have chronic abdominal pain, a possible seizure that was followed up with an EEG and neuro evaluation all unremarkable.  Patient denies suicidal ideations once admitted therefore no further psych placement needed and she was discharged to subacute rehab. Today patient is coming from facility with complaints of altered mental status from baseline, increased fatigue, fevers, and hypoxia.  On 08/23 patient was diagnosed with COVID-19. Patient complains of some shortness of breath, cough, severe headache, abdominal pain but this appears chronic, numbness testing into her left lower leg.  States having reduced appetite but no loss of taste or smell. ASSESSMENT/PLAN: Severe COVID-19 infection with acute hypoxic respiratory failure - First onset of symptoms: unknown, roughly week - Tested Positive: 8/23 - Decadron: 6mg PO daily, day #1 - continue home PPI - Give Remdesivir      *Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required. - Oxygen Requirements: 2L, wean as tolerated - COVID lab panel:              - D-Dimer = ordered              - CRP = ordered              - alkaline phosphatase = 244 - DVT Prophylaxis: Heparin - treat CHF keeping euvolemic, encourage proning, IS - PRN albuterol, tessalon, tylenol   Superimposed Bacterial CAP - procal mildly elevated at 0.29 - ER started Rocephin day 1/5 and Azithromycin day 1/3 - sputum culture, legionella, strep pneumoniae, blood cultures ordered    Acute exacerbation of chronic diastolic CHF  -last echo 6/12/21 EF 57%, diastolic dysfunction grade 2, right ventricle mildly to moderately decreased, mild MR, moderate TR right ventricular systolic pressure 43.1 mmHg -chest x-ray shows findings of mild congestion; BNP 17,476 -start Lasix 40 mg IV push 2 times a day    *The patient is on IV Lasix which requires daily monitoring of electrolyte and renal function to monitor for the following toxicities:  renal failure, hyper/hyponatremia, hypokalemia, metabolic alkalosis. -2 L fluid restriction, strict I&Os, daily weights   Indeterminate high sensitivity troponins -trope 61 with a 2 hour delta of +3 -demand ischemia from CHF exacerbation and in the presence of CKD
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased, Fatigue, Headache
Clinical narrative: Patient hospitalized with COVID-19;  Still hospitalized (ICU);  Fully vaccinated.   Admission Note H&P:  HISTORY OF PRESENT ILLNESS: Patient is a 73-year-old female with past medical history of diastolic CHF, hypertension, hyperlipidemia, seizure disorder s/p VNS, coronary artery disease status post CABG, sick sinus syndrome status post permanent pacemaker, CKD 3, diabetes type 2, GERD. Patient was recently hospitalized from 06/11/2021 to 6/20 3/21 for acute congestive heart failure found to have chronic diastolic CHF.  Patient during this visit was suicidal and was EN route to facility when she developed chest pain and taken to Hospital.  During hospitalization patient was noted to have chronic abdominal pain, a possible seizure that was followed up with an EEG and neuro evaluation all unremarkable.  Patient denies suicidal ideations once admitted therefore no further psych placement needed and she was discharged to subacute rehab. Today patient is coming from facility with complaints of altered mental status from baseline, increased fatigue, fevers, and hypoxia.  On 08/23 patient was diagnosed with COVID-19. Patient complains of some shortness of breath, cough, severe headache, abdominal pain but this appears chronic, numbness testing into her left lower leg.  States having reduced appetite but no loss of taste or smell. ASSESSMENT/PLAN: Severe COVID-19 infection with acute hypoxic respiratory failure - First onset of symptoms: unknown, roughly week - Tested Positive: 8/23 - Decadron: 6mg PO daily, day #1 - continue home PPI - Give Remdesivir      *Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required. - Oxygen Requirements: 2L, wean as tolerated - COVID lab panel:              - D-Dimer = ordered              - CRP = ordered              - alkaline phosphatase = 244 - DVT Prophylaxis: Heparin - treat CHF keeping euvolemic, encourage proning, IS - PRN albuterol, tessalon, tylenol   Superimposed Bacterial CAP - procal mildly elevated at 0.29 - ER started Rocephin day 1/5 and Azithromycin day 1/3 - sputum culture, legionella, strep pneumoniae, blood cultures ordered    Acute exacerbation of chronic diastolic CHF  -last echo 6/12/21 EF 57%, diastolic dysfunction grade 2, right ventricle mildly to moderately decreased, mild MR, moderate TR right ventricular systolic pressure 43.1 mmHg -chest x-ray shows findings of mild congestion; BNP 17,476 -start Lasix 40 mg IV push 2 times a day    *The patient is on IV Lasix which requires daily monitoring of electrolyte and renal function to monitor for the following toxicities:  renal failure, hyper/hyponatremia, hypokalemia, metabolic alkalosis. -2 L fluid restriction, strict I&Os, daily weights   Indeterminate high sensitivity troponins -trope 61 with a 2 hour delta of +3 -demand ischemia from CHF exacerbation and in the presence of CKD
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Hypoxia, Intervertebral disc degeneration, Lung opacity, Mental status changes
Clinical narrative: Patient hospitalized with COVID-19;  Still hospitalized (ICU);  Fully vaccinated.   Admission Note H&P:  HISTORY OF PRESENT ILLNESS: Patient is a 73-year-old female with past medical history of diastolic CHF, hypertension, hyperlipidemia, seizure disorder s/p VNS, coronary artery disease status post CABG, sick sinus syndrome status post permanent pacemaker, CKD 3, diabetes type 2, GERD. Patient was recently hospitalized from 06/11/2021 to 6/20 3/21 for acute congestive heart failure found to have chronic diastolic CHF.  Patient during this visit was suicidal and was EN route to facility when she developed chest pain and taken to Hospital.  During hospitalization patient was noted to have chronic abdominal pain, a possible seizure that was followed up with an EEG and neuro evaluation all unremarkable.  Patient denies suicidal ideations once admitted therefore no further psych placement needed and she was discharged to subacute rehab. Today patient is coming from facility with complaints of altered mental status from baseline, increased fatigue, fevers, and hypoxia.  On 08/23 patient was diagnosed with COVID-19. Patient complains of some shortness of breath, cough, severe headache, abdominal pain but this appears chronic, numbness testing into her left lower leg.  States having reduced appetite but no loss of taste or smell. ASSESSMENT/PLAN: Severe COVID-19 infection with acute hypoxic respiratory failure - First onset of symptoms: unknown, roughly week - Tested Positive: 8/23 - Decadron: 6mg PO daily, day #1 - continue home PPI - Give Remdesivir      *Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required. - Oxygen Requirements: 2L, wean as tolerated - COVID lab panel:              - D-Dimer = ordered              - CRP = ordered              - alkaline phosphatase = 244 - DVT Prophylaxis: Heparin - treat CHF keeping euvolemic, encourage proning, IS - PRN albuterol, tessalon, tylenol   Superimposed Bacterial CAP - procal mildly elevated at 0.29 - ER started Rocephin day 1/5 and Azithromycin day 1/3 - sputum culture, legionella, strep pneumoniae, blood cultures ordered    Acute exacerbation of chronic diastolic CHF  -last echo 6/12/21 EF 57%, diastolic dysfunction grade 2, right ventricle mildly to moderately decreased, mild MR, moderate TR right ventricular systolic pressure 43.1 mmHg -chest x-ray shows findings of mild congestion; BNP 17,476 -start Lasix 40 mg IV push 2 times a day    *The patient is on IV Lasix which requires daily monitoring of electrolyte and renal function to monitor for the following toxicities:  renal failure, hyper/hyponatremia, hypokalemia, metabolic alkalosis. -2 L fluid restriction, strict I&Os, daily weights   Indeterminate high sensitivity troponins -trope 61 with a 2 hour delta of +3 -demand ischemia from CHF exacerbation and in the presence of CKD
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mitral valve incompetence, Neurological examination normal, Pelvic fluid collection, Pleural effusion, Pyrexia
Clinical narrative: Patient hospitalized with COVID-19;  Still hospitalized (ICU);  Fully vaccinated.   Admission Note H&P:  HISTORY OF PRESENT ILLNESS: Patient is a 73-year-old female with past medical history of diastolic CHF, hypertension, hyperlipidemia, seizure disorder s/p VNS, coronary artery disease status post CABG, sick sinus syndrome status post permanent pacemaker, CKD 3, diabetes type 2, GERD. Patient was recently hospitalized from 06/11/2021 to 6/20 3/21 for acute congestive heart failure found to have chronic diastolic CHF.  Patient during this visit was suicidal and was EN route to facility when she developed chest pain and taken to Hospital.  During hospitalization patient was noted to have chronic abdominal pain, a possible seizure that was followed up with an EEG and neuro evaluation all unremarkable.  Patient denies suicidal ideations once admitted therefore no further psych placement needed and she was discharged to subacute rehab. Today patient is coming from facility with complaints of altered mental status from baseline, increased fatigue, fevers, and hypoxia.  On 08/23 patient was diagnosed with COVID-19. Patient complains of some shortness of breath, cough, severe headache, abdominal pain but this appears chronic, numbness testing into her left lower leg.  States having reduced appetite but no loss of taste or smell. ASSESSMENT/PLAN: Severe COVID-19 infection with acute hypoxic respiratory failure - First onset of symptoms: unknown, roughly week - Tested Positive: 8/23 - Decadron: 6mg PO daily, day #1 - continue home PPI - Give Remdesivir      *Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required. - Oxygen Requirements: 2L, wean as tolerated - COVID lab panel:              - D-Dimer = ordered              - CRP = ordered              - alkaline phosphatase = 244 - DVT Prophylaxis: Heparin - treat CHF keeping euvolemic, encourage proning, IS - PRN albuterol, tessalon, tylenol   Superimposed Bacterial CAP - procal mildly elevated at 0.29 - ER started Rocephin day 1/5 and Azithromycin day 1/3 - sputum culture, legionella, strep pneumoniae, blood cultures ordered    Acute exacerbation of chronic diastolic CHF  -last echo 6/12/21 EF 57%, diastolic dysfunction grade 2, right ventricle mildly to moderately decreased, mild MR, moderate TR right ventricular systolic pressure 43.1 mmHg -chest x-ray shows findings of mild congestion; BNP 17,476 -start Lasix 40 mg IV push 2 times a day    *The patient is on IV Lasix which requires daily monitoring of electrolyte and renal function to monitor for the following toxicities:  renal failure, hyper/hyponatremia, hypokalemia, metabolic alkalosis. -2 L fluid restriction, strict I&Os, daily weights   Indeterminate high sensitivity troponins -trope 61 with a 2 hour delta of +3 -demand ischemia from CHF exacerbation and in the presence of CKD
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Renal cyst, Respiratory tract congestion, SARS-CoV-2 test positive, Suicidal behaviour, Tricuspid valve incompetence
Clinical narrative: Patient hospitalized with COVID-19;  Still hospitalized (ICU);  Fully vaccinated.   Admission Note H&P:  HISTORY OF PRESENT ILLNESS: Patient is a 73-year-old female with past medical history of diastolic CHF, hypertension, hyperlipidemia, seizure disorder s/p VNS, coronary artery disease status post CABG, sick sinus syndrome status post permanent pacemaker, CKD 3, diabetes type 2, GERD. Patient was recently hospitalized from 06/11/2021 to 6/20 3/21 for acute congestive heart failure found to have chronic diastolic CHF.  Patient during this visit was suicidal and was EN route to facility when she developed chest pain and taken to Hospital.  During hospitalization patient was noted to have chronic abdominal pain, a possible seizure that was followed up with an EEG and neuro evaluation all unremarkable.  Patient denies suicidal ideations once admitted therefore no further psych placement needed and she was discharged to subacute rehab. Today patient is coming from facility with complaints of altered mental status from baseline, increased fatigue, fevers, and hypoxia.  On 08/23 patient was diagnosed with COVID-19. Patient complains of some shortness of breath, cough, severe headache, abdominal pain but this appears chronic, numbness testing into her left lower leg.  States having reduced appetite but no loss of taste or smell. ASSESSMENT/PLAN: Severe COVID-19 infection with acute hypoxic respiratory failure - First onset of symptoms: unknown, roughly week - Tested Positive: 8/23 - Decadron: 6mg PO daily, day #1 - continue home PPI - Give Remdesivir      *Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required. - Oxygen Requirements: 2L, wean as tolerated - COVID lab panel:              - D-Dimer = ordered              - CRP = ordered              - alkaline phosphatase = 244 - DVT Prophylaxis: Heparin - treat CHF keeping euvolemic, encourage proning, IS - PRN albuterol, tessalon, tylenol   Superimposed Bacterial CAP - procal mildly elevated at 0.29 - ER started Rocephin day 1/5 and Azithromycin day 1/3 - sputum culture, legionella, strep pneumoniae, blood cultures ordered    Acute exacerbation of chronic diastolic CHF  -last echo 6/12/21 EF 57%, diastolic dysfunction grade 2, right ventricle mildly to moderately decreased, mild MR, moderate TR right ventricular systolic pressure 43.1 mmHg -chest x-ray shows findings of mild congestion; BNP 17,476 -start Lasix 40 mg IV push 2 times a day    *The patient is on IV Lasix which requires daily monitoring of electrolyte and renal function to monitor for the following toxicities:  renal failure, hyper/hyponatremia, hypokalemia, metabolic alkalosis. -2 L fluid restriction, strict I&Os, daily weights   Indeterminate high sensitivity troponins -trope 61 with a 2 hour delta of +3 -demand ischemia from CHF exacerbation and in the presence of CKD
Age: 77.0
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: After receiving vaccine, patient broke out in shingles as confirmed by his provider on 07/19/21/  A course of valacylovir 1gm, doing 1 tid was dispensed for a 7 day supply.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lymph node pain, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Swollen lymph nodes and tenderness on left side, starting within 24 hours and persisting for 14 days (and counting) after vaccination. Not resolved Pain and stiffness in left arm, shoulder and neck starting after vaccination and persisting for 14 days after vaccination. Not resolved Headaches, temporarily resolved by OTC treatment (Advil, Tylenol) but recurring.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Swollen lymph nodes and tenderness on left side, starting within 24 hours and persisting for 14 days (and counting) after vaccination. Not resolved Pain and stiffness in left arm, shoulder and neck starting after vaccination and persisting for 14 days after vaccination. Not resolved Headaches, temporarily resolved by OTC treatment (Advil, Tylenol) but recurring.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: Patient completed Moderna COVID-19 vaccine series 4/7/2021 and 5/7/2021. Patient then received Pfizer dose as documented on this report on 8/4/2021.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema of eyelid, Eyelid pain, Lacrimation increased, Swelling of eyelid
Clinical narrative: On 08/27/2021, my left lower eye lid became quite red and painful, a lot of weeping from the eye or tearing. On 08/31/2021, I went to see my doctor. She wondered if I didn't have an allergic reaction. She wanted me to call her the next day, 09/01/2021 and it wasn't getting better. I went to the vision care clinic, she prescribed the antibiotics, Keflex, the pharmacy gave me cephalexin. I got 5 doses in and it wasn't getting better. On 09/02/2021 I saw her partner and it was worse I had a large bump and it was painful. He examined my eye and gave me a steroid drops and told me to continue the prescription plan. He told me to continue with the antibiotics and icing. I am not totally recovered from the AE, but it has improved, you can still see there is a little growth or lump there, about a 1/4 of an inch. It's small and not painful today and I think I am on the road to recovery.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal paraesthesia, Vaccine positive rechallenge
Clinical narrative: At approximately 1626, patient reported tingling of throat to RN. Patient denied difficulty breathing, difficulty swallowing, itchiness and rashes. RN offered to take vital signs. Patient denied vitals signs. RN offered diphenhydramine. Patient denied diphenhydramine. Patient reported "I'm fine". Patient given water. Patient able to drink water. Patient reported similar reaction to the first dose of Pfizer Covid Vaccine (LOT# EW0168, exp. 08/2021) administered on 08/10/21. Patient reported she felt the "same thing" and "didn't say anything". Patient reported it "felt like a panic attack starting". At 1634, RN reassessed patient. Patient reported "it didn't get any worse". Patient denied itchiness, rashes, difficulty breathing and difficulty swallowing. RN offered diphenhydramine. Patient denied diphenhydramine. RN offered to take vital signs. Patient denied vital signs. At 1642, RN reassessed patient. Patient reported the symptom had "gone down". Patient denied itchiness, rashes, difficulty breathing, difficulty swallowing. RN offered diphenhydramine. Patient denied diphenhydramine. RN offered to take vital signs. Patient denied vitals signs. At 1645, RN reassessed patient. Patient reported the symptom is "gone". Patient denied itchiness, rashes, difficulty breathing and difficulty swallowing. RN educated patient on signs/symptoms of when to seek emergency care, to follow up with primary care provider, and to sign up on v-safe. At 1647, patient left facility with steady gait and unlabored respirations.
Age: 36.0
Sex: F
Vaccine: FLU4
Symptoms: Muscular weakness, Pain in extremity, Weight bearing difficulty
Clinical narrative: Severe muscle weakness and pain in left forearm, no pain/weakness in upper arm at site of injection. Pt has trouble lifting or doing much with her arm. Pt does not have any pain or weekness in right arm.  Pt reports no swelling, redness or heat in painful arm.  Since it has only been a couple of days since vaccination, and there were no signs of infection I advised pt to wait 2 more days and if there was no improvement at that point to contact her doctor.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Musculoskeletal stiffness, Peripheral swelling, Rash
Clinical narrative: About 45 minutes after receiving the vaccine, she developed a systemic rash followed by jives. Her right arm developed some swelling and then some numbness and stiffness. She states she developed a headache behind  her eyes. BP 131/75 at 1232 with HR 102 and Pulse Ox95. At 1237 BP 127/77, HR 104 and Pulse Ox 95. SHe was taken to the ED to be evaluated
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: About 45 minutes after receiving the vaccine, she developed a systemic rash followed by jives. Her right arm developed some swelling and then some numbness and stiffness. She states she developed a headache behind  her eyes. BP 131/75 at 1232 with HR 102 and Pulse Ox95. At 1237 BP 127/77, HR 104 and Pulse Ox 95. SHe was taken to the ED to be evaluated
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Headache, Hypoaesthesia, Injection site pain, Musculoskeletal stiffness
Clinical narrative: About 45 minutes after receiving the vaccine, she developed a systemic rash followed by jives. Her right arm developed some swelling and then some numbness and stiffness. She states she developed a headache behind  her eyes. BP 131/75 at 1232 with HR 102 and Pulse Ox95. At 1237 BP 127/77, HR 104 and Pulse Ox 95. SHe was taken to the ED to be evaluated
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Swelling, Urticaria, Vision blurred
Clinical narrative: About 45 minutes after receiving the vaccine, she developed a systemic rash followed by jives. Her right arm developed some swelling and then some numbness and stiffness. She states she developed a headache behind  her eyes. BP 131/75 at 1232 with HR 102 and Pulse Ox95. At 1237 BP 127/77, HR 104 and Pulse Ox 95. SHe was taken to the ED to be evaluated
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Diarrhoea, Lymph node pain, Nausea, Pain in extremity
Clinical narrative: Tingling in my throat and tongue, Nausea, Diarrhea, Hives, My whole body was tingling and itchy, Pain in my left leg Lymph nodes under both armpits.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Pharyngeal paraesthesia, Pruritus, Urticaria
Clinical narrative: Tingling in my throat and tongue, Nausea, Diarrhea, Hives, My whole body was tingling and itchy, Pain in my left leg Lymph nodes under both armpits.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death
Clinical narrative: Fully vaccinated patient tested positive 8/28/2021 and hospitialized then expired 09/03/2021.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Erythema, Palpitations
Clinical narrative: 3 days after test patient notes occasional palpitations and redness at arm. She reports a similar reaction with 1st dose.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, Malaise, Streptococcus test positive
Clinical narrative: The morning of  August 2, 2021 I went to the urgent care and they did a Strep throat test and it came back positive. An then by Wednesday August 4, 2021 I couldn't smell or taste anything. I went to be and I was sick for about two weeks. I had no energy and I was very weak and couldn't do anything. I believe that I had come down with COVID-19. But I didn't have a fever at all. Urgent care prescribe me, Amoxicillin for 10 days. As of today Sept. 07, 2021 I still can't taste or smell.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Rash
Clinical narrative: Rash, tightness in chest, chest pain
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Infection, SARS-CoV-2 test positive
Clinical narrative: Client was vaccinated for Covid on 3/26 and 4/22/2021.  Was exposed to someone with Covid and was tested on 9/1 and 9/3.  PCR tests positive and client had no symptoms.  Reported as a case of breakthrough Covid in a fully vaccinated person.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site erythema, Injection site pruritus
Clinical narrative: PT SAYS APPOX 2 DAYS AFTER RECIEVING VACCINE  SHE BEGAN TO ITCH AROUND THE SITE OF ARM.  PT CAME TO STORE  1 WEEK LATER.  LEFT AREA HAS A SMALL BRUISING AREA AROUND INJECTION SITE  AND SOME REDNESS ON UPPER ARM.  PT HAD NOT ICED IT BUT DID PUT SOME CREAM ON IT SHE THINKS IT MIGHT BE ANTIBIOTIC.  SHE SAYS IT STILL ITCHES.  SO I RECOMMEND SHE SEE HER DR.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Blood urine present, COVID-19, COVID-19 pneumonia, Condition aggravated
Clinical narrative: Type 2 diabetes mellitus well controlled, Blood in urine, Atrial fibrillation with rapid ventricular response., Pneumonia caused by SARS-CoV-2
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Type 2 diabetes mellitus
Clinical narrative: Type 2 diabetes mellitus well controlled, Blood in urine, Atrial fibrillation with rapid ventricular response., Pneumonia caused by SARS-CoV-2
Age: 73.0
Sex: M
Vaccine: FLU4
Symptoms: Rash maculo-papular, Rash pruritic
Clinical narrative: Generalized maculopapular, pruritic rash to  bilateral arms, legs, abdomen.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Patient stated that she received a seizure. She has never had a seizure before. It lasted about 30seconds. Patient stated that she did not go to the Dr but she did reach out to her PCP to let her know what happened.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac disorder, Chills, Gastrointestinal pain, Injection site erythema, Injection site inflammation
Clinical narrative: 1st Dose: Within 12 hours, fever, body aches, chills. Gone by next day. 2nd Dose: Within 12 hours, fever, body aches, chills, infrequent heart pain, nausea, vomiting, dull intestinal pain. Gone after day and a half. After two days, inflammation of muscle tissue underneath shot; skin was red, hot to touch, and raised/a lump. "Covid arm" lasted about a week; symptoms went away.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site mass, Injection site warmth, Nausea, Pain, Pyrexia
Clinical narrative: 1st Dose: Within 12 hours, fever, body aches, chills. Gone by next day. 2nd Dose: Within 12 hours, fever, body aches, chills, infrequent heart pain, nausea, vomiting, dull intestinal pain. Gone after day and a half. After two days, inflammation of muscle tissue underneath shot; skin was red, hot to touch, and raised/a lump. "Covid arm" lasted about a week; symptoms went away.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: 1st Dose: Within 12 hours, fever, body aches, chills. Gone by next day. 2nd Dose: Within 12 hours, fever, body aches, chills, infrequent heart pain, nausea, vomiting, dull intestinal pain. Gone after day and a half. After two days, inflammation of muscle tissue underneath shot; skin was red, hot to touch, and raised/a lump. "Covid arm" lasted about a week; symptoms went away.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: hx of renal transplant, hypoxia, positive COVID test
Age: 14.0
Sex: F
Vaccine: UNK
Symptoms: Brain natriuretic peptide increased, Cardiomyopathy, Chest pain, Echocardiogram, Electrocardiogram ambulatory
Clinical narrative: She was playing in a soccer game and developed chest pain and extreme fatigue. She went to the ER and had elevated troponin and BNP. Was diagnosed with cardiomyopathy.  She is now 2 weeks out and still unable to do any activity that elevates her heart rate. She had follow up labs one week later and cardiac inflammatory markers have returned to normal. Echocardiogram and Holter monitor still pending results
Age: 14.0
Sex: F
Vaccine: UNK
Symptoms: Fatigue, Inflammatory marker test, Laboratory test, Loss of personal independence in daily activities, Troponin increased
Clinical narrative: She was playing in a soccer game and developed chest pain and extreme fatigue. She went to the ER and had elevated troponin and BNP. Was diagnosed with cardiomyopathy.  She is now 2 weeks out and still unable to do any activity that elevates her heart rate. She had follow up labs one week later and cardiac inflammatory markers have returned to normal. Echocardiogram and Holter monitor still pending results
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Pain in extremity, Peripheral swelling
Clinical narrative: arm swelling ( shoulder to elbow), sore arm, fatigue, headache, general sick feeling
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: PT VACCINATED WITH PFIZER ON 1/7/21 (LOT EL0140) + 2/24/21 (LOT EL0332). S/O BEGAN 9/1/21, TESTED + 9/2/21
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19 after being vaccinated.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin tightness, Urticaria
Clinical narrative: 17 minutes after vaccination, patient started having itching and tightness to face. Started with a few hives to right cheek. Benadryl 25 mg IM given and patient sent to emergency department
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Dizziness, Dyspnoea, Heart rate increased
Clinical narrative: 24hrs post vaccination, pt reported pain at the injection site and that she is unable to lift her arm.  Pt instructed to take APAP or Ibuprofen for pain until symptoms resolved.  On 8/6 pt reported difficulty breathing/wheezing/SOB, a rapid HR the night before, dizziness, weakness, and abdominal cramping. Pt instructed to go to UC/ED given hx of Asthma and pt report of SOB.  Pt stated they were going to Hospital.  No information regarding that encounter is available to this writer.  Pt recovered and was given 2nd dose on 8/27.  Pt did not report prior reaction at that time.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Mobility decreased, Wheezing
Clinical narrative: 24hrs post vaccination, pt reported pain at the injection site and that she is unable to lift her arm.  Pt instructed to take APAP or Ibuprofen for pain until symptoms resolved.  On 8/6 pt reported difficulty breathing/wheezing/SOB, a rapid HR the night before, dizziness, weakness, and abdominal cramping. Pt instructed to go to UC/ED given hx of Asthma and pt report of SOB.  Pt stated they were going to Hospital.  No information regarding that encounter is available to this writer.  Pt recovered and was given 2nd dose on 8/27.  Pt did not report prior reaction at that time.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Starting 2 days after administration of my second COVID-19 vaccine and ending approximately 2-1/2 months after receiving the vaccine my heart would start racing at random times of the day, often several times a day. I run 5 miles 3-4 times a week and have no heart issues. I had a CT Heart scan that showed 0% plaque and am at very low risk of heart disease due to level of physical fitness and appropriate height/weight for my whole life. Several times my heart would start racing in the middle of the night and would wake me out of a sound sleep. The episodes took 30-45 minutes to resolve. Not only was my heart racing at rest (would reach 168 bpm at 0% activity level) but I also experienced a higher heart rate than normal during my 5 mile runs. My heart rate would get 20 bpm higher than it normally does during these runs.  This was very scary and I visited my physician, Dr., because I was worried that it was related to the vaccine and I also worried about long term heart problems as a result of the 2-1/2 month period where my heart was racing for no reason/at rest.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Myalgia, Oedema peripheral
Clinical narrative: heavy, tight feeling from the top of the arm to the last tip of the finger. swollen armpit. muscle pain on left upper back shoulder. heavy pain comes and goes, gets worse at night feels like arm is to heavy and might fall off. A vaccine shouldn't be forced ..
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dysstasia, Fatigue, Feeling abnormal
Clinical narrative: Exactly 12 hours after administration I experienced these symptoms: Exploding headache, nausea, vomiting, chills, fever, dizziness, unable to stand up I had a partial loss of consciousness with the exploding headache.  This lasted for 6 1/2 hours.  Then the headache diminished to that of a severe migraine and I regained full consciousness.  Over the course of another 12 hours I gradually improved so that 24 hours after onset of severe reaction I could stand up, move around, and eat a little.  Some symptoms such as extreme fatigue and brain fog lasted for another week.     I have never had a headache like that and I hope I would never experience anything like that again.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Loss of consciousness, Migraine, Nausea, Pyrexia
Clinical narrative: Exactly 12 hours after administration I experienced these symptoms: Exploding headache, nausea, vomiting, chills, fever, dizziness, unable to stand up I had a partial loss of consciousness with the exploding headache.  This lasted for 6 1/2 hours.  Then the headache diminished to that of a severe migraine and I regained full consciousness.  Over the course of another 12 hours I gradually improved so that 24 hours after onset of severe reaction I could stand up, move around, and eat a little.  Some symptoms such as extreme fatigue and brain fog lasted for another week.     I have never had a headache like that and I hope I would never experience anything like that again.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Exactly 12 hours after administration I experienced these symptoms: Exploding headache, nausea, vomiting, chills, fever, dizziness, unable to stand up I had a partial loss of consciousness with the exploding headache.  This lasted for 6 1/2 hours.  Then the headache diminished to that of a severe migraine and I regained full consciousness.  Over the course of another 12 hours I gradually improved so that 24 hours after onset of severe reaction I could stand up, move around, and eat a little.  Some symptoms such as extreme fatigue and brain fog lasted for another week.     I have never had a headache like that and I hope I would never experience anything like that again.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Soreness in shoulder at vaccination site. It still persists to this day.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Syncope
Clinical narrative: had a couple of fainting episodes after first vaccine, but collapsed and was hospitalized 2 days after second dose
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Blindness unilateral, Computerised tomogram, Dysarthria, Gait disturbance
Clinical narrative: Rash, headache, lymph nodes swelling, fever all happened within an hour. Hair loss within a few days,  still falling out.  Had a headache through June, on June 5th I lost vision in my right eye, and mobility on my right side.  Had dealing problems and slurred speech. Still receiving therapy to walk and get back to day to day normals
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Laboratory test, Loss of personal independence in daily activities, Lymphadenopathy, Magnetic resonance imaging
Clinical narrative: Rash, headache, lymph nodes swelling, fever all happened within an hour. Hair loss within a few days,  still falling out.  Had a headache through June, on June 5th I lost vision in my right eye, and mobility on my right side.  Had dealing problems and slurred speech. Still receiving therapy to walk and get back to day to day normals
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pyrexia, Rash
Clinical narrative: Rash, headache, lymph nodes swelling, fever all happened within an hour. Hair loss within a few days,  still falling out.  Had a headache through June, on June 5th I lost vision in my right eye, and mobility on my right side.  Had dealing problems and slurred speech. Still receiving therapy to walk and get back to day to day normals
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dizziness, Fatigue, Headache
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Unable to Sleep-Severe, Additional Details: numbess- arm and fingertips, tingling - arm
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site pain, Insomnia, Pain, Paraesthesia
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Unable to Sleep-Severe, Additional Details: numbess- arm and fingertips, tingling - arm
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy skin, Eczema, Rash, Swelling, Swelling face
Clinical narrative: patient developed 3 - 4 days later rash and swelling of face, eyelids and neck.  lasted 2 weeks 4 hours after the second vaccine, patient again developed face, eyelid swelling and then developed severe rash on legs, arms, back, buttocks that lasted until mid August, now gradually fading
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling of eyelid
Clinical narrative: patient developed 3 - 4 days later rash and swelling of face, eyelids and neck.  lasted 2 weeks 4 hours after the second vaccine, patient again developed face, eyelid swelling and then developed severe rash on legs, arms, back, buttocks that lasted until mid August, now gradually fading
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: about 10 minutes after pfizer covid vaccine administration, pt reported feeling slight dizzy. I said I would call 911 and asked if she has touble breathing. pt said no it is not serious. another 2 to 3 minutes later, pt got up and said she is feeling completely fine. I asked her to stay a little longer, but she said is no longer dizzy and she is able to go home and did not want to stay in the store any longer. I did call her about half hour later and she is completely fine.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Breast cellulitis, Breast discolouration, Breast haemorrhage, Breast inflammation
Clinical narrative: 2nd day Monday, 15th, swelling on the left breast and inner was red and swelling, My arm was sore. 16th the breast started changed color to purple. the following day it burst and blood was oozing out.  I went to urgent and they sent to ER and 1 was. The wound was open and given anti biotics and had flu like symptoms. I had a blood clots in my arms.  Notes - left arm , lymph notes was swelling for 1st dose. hospital for 6 days. Shot on Sat and Sunday I got tenderness. sore and then bursting at work.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, C-reactive protein increased, Connective tissue inflammation, Culture wound negative, Erythema
Clinical narrative: 2nd day Monday, 15th, swelling on the left breast and inner was red and swelling, My arm was sore. 16th the breast started changed color to purple. the following day it burst and blood was oozing out.  I went to urgent and they sent to ER and 1 was. The wound was open and given anti biotics and had flu like symptoms. I had a blood clots in my arms.  Notes - left arm , lymph notes was swelling for 1st dose. hospital for 6 days. Shot on Sat and Sunday I got tenderness. sore and then bursting at work.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lymphadenopathy, Pain in extremity, SARS-CoV-2 test negative, Skin infection
Clinical narrative: 2nd day Monday, 15th, swelling on the left breast and inner was red and swelling, My arm was sore. 16th the breast started changed color to purple. the following day it burst and blood was oozing out.  I went to urgent and they sent to ER and 1 was. The wound was open and given anti biotics and had flu like symptoms. I had a blood clots in my arms.  Notes - left arm , lymph notes was swelling for 1st dose. hospital for 6 days. Shot on Sat and Sunday I got tenderness. sore and then bursting at work.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Thrombosis, Wound secretion
Clinical narrative: 2nd day Monday, 15th, swelling on the left breast and inner was red and swelling, My arm was sore. 16th the breast started changed color to purple. the following day it burst and blood was oozing out.  I went to urgent and they sent to ER and 1 was. The wound was open and given anti biotics and had flu like symptoms. I had a blood clots in my arms.  Notes - left arm , lymph notes was swelling for 1st dose. hospital for 6 days. Shot on Sat and Sunday I got tenderness. sore and then bursting at work.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: hx cardiopulmonary disease, dyspnea, hypoxia, positive COVID test